The Department of Lung Transplantation of FAHZU was established on June 1, 2016. It is an exclusive diagnosis and treatment centre for end-stage lung disease in Zhejiang Province. In 2016, we had completed five cases of lung transplant within six months. By the end of 2019, 56 cases of lung transplantation have been completed, including 1 case of heart-lung transplantation, and the number of transplants ranks fifth in China. Especially in 2019, no lung transplant recipients die during the perioperative period, which is at the pinnacle level in the world. In 2017, we had completed bilateral lung transplantation for a patient who was diagnosed as "Kartegener Syndrome". This is the first case in Zhejiang Province(the second in China, and the twelfth in the world). On March 1, 2020, we had completed bilateral lung transplantation for an elderly female patient with COVID-19 pneumonia, which was the first lung transplantation for elderly end-stage COVID-19 patients in the world. Once more, a 70-year-old man with COVID-19 pneumonia underwent bilateral lung transplantation one week later in our centre. At present, more than 800 cases of thoracotomy were performed every year, and more than 90% of operations were thoracoscopy, including all types of thoracic surgery diseases, such as lung cancer (especially locally advanced lung cancer), oesophagal cancer, and mediastinal tumour.
There are 13 doctors work in the lung transplantation department, including three senior titles. The lung transplant team are composed of excellent and specialized medical staffs. The main technical staffs studied lung transplantation technology at the Toronto General Hospital (TGH) in Canada and received personal guidance from Professor Shaf Kashavjee, a contemporary master of lung transplantation. They systematically learned the selection of lung transplant recipients, lung acquisition, the whole process of operation, postoperative monitoring, long-term follow-up and the principle of lung transplantation. They have mastered the evaluation system and standard surgical skills.
Treatments and Services
Our team perform lung transplantation for end stage lung disease. Meanwhile, more than 800 cases of thoracotomy were performed every year, and more than 90% of operations were thoracoscopy, including all types of thoracic surgery diseases, such as lung cancer (especially locally advanced lung cancer), oesophagal cancer, and mediastinal tumour.
Research & Innovation
Han Weili, the director of the Department of Lung Transplantation, is the academic leader of Lung Transplantation in Zhejiang Province. He had published more than ten SCI-Indexed Papers as the first or corresponding author and published more than ten scientific papers in domestic core journals. He had presided one project of the National Natural Science Foundation of China, one project of the Natural Science Foundation of Zhejiang Province, and eight fundamental pieces of research on various chest tumours.
Education & Training
The Department of Lung Transplantation is deeply committed to training expert clinicians, clinical investigators, and medical educators who will go on to be future leaders in the field.
Honors & Awards
Dr. Han Weili attends a number of domestic and international academic conferences every year. He was outstanding worker of Zhejiang University School of Medicine.